# US 2019/0194766 A1 · Nucleic acid amplification assays for detection of pathogens

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0194766 A1
- Document ID: US20190194766A1
- Status: Published application
- Kind: A1
- Application number: 16/328,548
- Filed: 2017-08-25
- Published: 2019-06-27
- Earliest claimed: 2016-08-26
- Assignees: The Broad Institute, Inc.; Massachusetts Institute of Technology; President and Fellows of Harvard College
- Applicants: The Broad Institute, Inc.; Massachusetts Institute of Technology; President and Fellows of Harvard College
- Inventors: Mary Lynn BANIECKI; Hayden METSKY; Pardis SABETI
- Web page: https://patentgrep.com/patent/US20190194766A1

## CPC

- C12Q 1/702: {for retroviruses}
- C12Q 1/6893: for protozoa
- C12Q 1/701: {Specific hybridization probes}
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- C12Q 2600/158: Expression markers
- G16B 30/10: Sequence alignment; Homology search
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

The present invention relates to a method for generating primers and/or probes for use in analyzing a sample which may comprise a pathogen target sequence comprising providing a set of input genomic sequence to one or more target pathogens, generating a set of target sequences from the set of input genomic sequences, identifying one or more highly conserved target sequences, and generating one or more primers, one or more probes, or a primer pair and probe combination based on the one or more conserved target sequences.

## Claims

### Claim 1

A method for developing probes and primers to pathogens, comprising:
providing a set of input genomic sequences to one or more target pathogens;
generating a set of target sequences from the set of input genomic sequences;
applying a set cover solving process to the set of target sequences to identify one or more target amplification sequences, wherein the one or more target amplification sequences are highly conserved target sequences shared between the set of input genomic sequences of the target pathogen; and
generating one or more primers, one or more probes, or a primer pair and probe combination based on the one or more target amplification sequences.

### Claim 2 (depends on 1)

The method of claim 1, wherein the set of input genomic sequences represent genomic sequences from two or more variants of the target pathogen.

### Claim 3 (depends on 2)

The method of claim 2, wherein the set input genomic sequences represent genomic sequence from two or more target pathogens.

### Claim 4 (depends on 2, 3)

The method of claims 2 or 3, wherein the one or more target pathogens is one or more viral pathogens.

### Claim 5 (depends on 4)

The method of claim 4, wherein the viral pathogen is Ebola Dengue, Lassa, or a combination thereof.

### Claim 6 (depends on 4)

The method of claim 4, wherein the one or more pathogens is a parasitic pathogen.

### Claim 7 (depends on 7)

The method of claim 7, wherein the parasitic pathogen is Babesia microti.

### Claim 8 (depends on 1)

The method of claim 1, wherein the target sequences are fragmented to a size that is approximately equal to a size of an amplicon for detection using a nucleic acid amplification assay.

### Claim 9 (depends on 8)

The method of claim 8, wherein the size of the target sequence is 100 to 500 base pairs.

### Claim 10 (depends on 1)

The method of claim 1, wherein each nucleotide of the set of input genomic sequences is considered an element of universe of the set cover solving process and wherein each element is considered covered if the target sequence aligns to some portion of a genomic reference sequence.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

A method for detecting one or more pathogens comprising:
contacting a sample with one or more primers and/or probes generated using any one of the methods of claims 1 to 10; and
detecting amplification of one or more pathogen target sequences using a nucleic acid amplification method and the one or more primers and/or probes, wherein detection of the target sequence indicates a presence of the one or more pathogens in the sample.

### Claim 12 (depends on 11)

The method of claim 11, wherein the nucleic acid amplification method is quantitative PCR and the one or more primers and/or probes comprise a forward and reverse primers and a probe modified with a detectable label.

### Claim 13

A method for detecting Ebola in samples, comprising:
contacting a sample with a forward and reverse primer and a probe with a detectable label, wherein the forward primer comprises SEQ ID NO: 1, the reverse primer comprises SEQ ID NO: 2, and the probe comprises SEQ ID NO: 3; and
detecting amplification of one or more target sequences by quantitative PCR using the forward primer, reverse primer, and the probe, wherein detection of the one or more target sequences indicates the presence of Ebola.

### Claim 14

A method for detecting Dengue in samples, comprising:
contacting a sample with a forward and reverse primer and a probe with a detectable label, wherein the forward primer comprises SEQ ID NO: 45, the reverse primer comprises SEQ ID NO: 46, and the probe comprises SEQ ID NO: 47; and
detecting amplification of one or more target sequences by quantitative PCR using the forward primer, reverse primer, and the probe, wherein detection of the one or more target sequences indicates the presence of Dengue.

### Claim 15

A method for detecting Lassa in samples, comprising:
contacting a sample with a forward and reverse primer wherein the forward primer comprises SEQ ID Nos: 50 or 56, the reverse primer comprises SEQ ID NOs: 54 or 57; and
detecting amplification of one or more target sequences by quantitative PCR using the forward primer, reverse primer, and the probe, wherein detection of the one or more target sequences indicates the presence of Lassa.

### Claim 16

A method for detecting Babesia microti in samples, comprising:
contacting a sample with a forward and reverse primer and a probe with a detectable label, wherein the forward primer comprises SEQ ID NO: 49, the reverse primer comprises SEQ ID NO: 50, and the probe comprises SEQ ID NO: 51; and
detecting amplification of one or more target sequences by quantitative PCR using the forward primer, reverse primer, and the probe, wherein detection of the one or more target sequences indicates the presence of Babesia microti.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

A kit comprising the primers and/or probes of any one of claims 1 to 16.
